Molecule Details
| InChIKey | YWCLDDLVLSQGSZ-JOCHJYFZSA-N |
|---|---|
| Compound Name | S-3304 |
| Canonical SMILES | Cc1ccc(C#Cc2ccc(S(=O)(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)O)s2)cc1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.3 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12149 |
|---|---|
| Drug Name | S-3304 |
| CAS Number | 203640-27-1 |
| Groups | investigational |
| ATC Codes | nan |
| Description | S-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non Small Cell Lung Cancer, among others. |
Categories: Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Matrix Metalloproteinase Inhibitors Protease Inhibitors Sulfur Compounds
Cross-references: BindingDB: 50063129 CHEMBL297792 ChemSpider: 8894295 PubChem:10718956 PubChem:347828445